Adhesion Protein Plays Double Agent, Key Role in Cell Migration
News Aug 18, 2015
The protein E-Cadherin (E-Cad) is a kind of adhesive that keep cells tightly bound together, thus favouring the organisation of tissues and organs. Scientists at the Institute for Research in Biomedicine (IRB Barcelona) now reveal a new function for E-Cad, one that contrasts with its accepted role in impeding cell movement. The researchers have published an article in which they report that this protein is crucial for the coordinated movement of diverse cell types.
This new function of E-Cad may explain why tumours that express intermediary levels of this protein have a poorer prognosis.
Coordinated cell movement
E-Cad facilitates the movement of heterogeneous groups of cells—understanding as heterogeneity cells that exert a range of activities because they have different genes activated: some may divide many times, others trigger certain hormones, while others interact with the membrane, etc...
Thanks to E-Cad, this group of diverse cells moves in a coordinated manner to its destination. Once there, the cells distribute where they are needed; their moderate levels of E-Cad keep them bound but not immobile during this migration. IRB Barcelona researchers Kyra Campbell and Jordi Casanova have addressed this phenomenon in the development of the embryonic digestive system of the fly Drosophila melanogaster, a model that allows them to study cell migration in a growing organism.
"Cell migration is a common and necessary process for an embryo and also for the correct function of the adult organism. What has been most surprising is the observation that E-Cad is a key component in cell movement, when its role was previously assumed to be that of keeping cells static," explains Jordi Casanova, head of the Development and Morphogenesis in Drosophila Lab at IRB Barcelona and CSIC research professor.
Cell migration is also of great biomedical relevance, and research into this phenomenon sheds light on how, for example, cancer metastasis and other processes such as wound healing and inflammation arise.
Cell migration and metastasis
According to Casanova, intermediary levels of E-Cad are often associated with aggressive tumours, precisely those which are capable of metastasising. He also reveals that, "the more we learn about metastases, the more evidence emerges that they are formed by groups of cells and not by individual ones".
E-Cad would facilitate highly diverse heterogeneous groups of cells to migrate together from the original tumour. "A cell that migrates alone is much easier to eliminate that a group of cells with different functions," explains the researcher.
"Our results in Drosophila are clinically relevant because they offer an explanation of the role that may be played by E-Cad in tumours with metastasis," says Casanova.
The study has involved the participation of researchers from Advanced Digital Microscopy Core Facility at IRB Barcelona, headed by Julien Colombelli. Sébastien Tosi, Senior Research Officer with this facility, set up the programmes to monitor cells in vivo during their migration.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE